Sharon Wigal, PhD


AVIDA Inc.


  • Advisory Board: Eli Lilly and Company; Ironshore Inc.; Neos Therapeutics, Inc.; NextWave Pharmaceuticals; Noven Pharmaceuticals, Inc.; Nutec Group; Pfizer Inc.; Rhodes Pharmaceuticals L.P.; Shionogi; Shire; Sunovion Pharmaceuticals Inc.; Tris Pharma, Inc.
  • Consultant: Eli Lilly and Company; Ironshore Inc.; Neos Therapeutics, Inc.; NextWave Pharmaceuticals; Noven Pharmaceuticals, Inc.; Nutec Group; Pfizer Inc.; Rhodes Pharmaceuticals L.P.; Shionogi; Shire; Sunovion Pharmaceuticals Inc.; Tris Pharma, Inc.
  • Grant Support: Eli Lilly and Company; Forest Laboratories, Inc.; Ironshore Inc.; NextWave Pharmaceuticals; Noven Pharmaceuticals, Inc.; Nutec Group; Purdue Pharma L.P.; Rhodes Pharmaceuticals L.P.; Shire; Sunovion Pharmaceuticals Inc.; Tris Pharma, Inc.
  • Research Support: Eli Lilly and Company; Forest Laboratories, Inc.; Ironshore Inc.; NextWave Pharmaceuticals; Noven Pharmaceuticals, Inc.; Nutec Group; Purdue Pharma L.P.; Rhodes Pharmaceuticals L.P.; Shire; Sunovion Pharmaceuticals Inc.; Tris Pharma, Inc.
  • Speakers Bureau: Eli Lilly and Company; Ironshore Inc.; Neos Therapeutics, Inc.; NextWave Pharmaceuticals; Noven Pharmaceuticals, Inc.; Pfizer Inc.; Shionogi; Shire; Sunovion Pharmaceuticals Inc.; Tris Pharma, Inc.
Copyright © 2015 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.